Improved discrimination of AD patients using β-amyloid (1 - 42) and tau levels in CSF - Hulstaert,F.; Blennow,K.; Ivanoiu,A.; Schoonderwaldt,H.C.; Riemenschneider,M.; De Deyn,P.P.; Bancher,C.; Cras,P.; Wiltfang,J.; Metha,P.D.; Iqbal,K.; Pottel,H.; et al. (Neurology, 1999)